Results 181 to 190 of about 56,087 (242)

Abortifacient Drugs and Devices: Medical and Moral Dilemmas [PDF]

, 1990
Severyn, Kristine M.
core   +1 more source

Sonographic and Clinical Progression of Adenomyosis and Coexisting Endometriosis: Long-Term Insights and Management Perspectives. [PDF]

J Pers Med
Martire FG, d'Abate C, Costantini E, De Bonis M, Sorrenti G, Centini G, Zupi E, Lazzeri L.   +7 more
europepmc   +1 more source

Reply to Douxfils, J.; Foidart, J.-M. Critical Considerations in the Interpretation of Bone Turnover Marker Data in HormonalContraceptive Users. Comment on "Tassi et al. Hormonal Contraception and Bone Metabolism: Emerging Evidence from a Systematic Review and Meta-Analysis of Studies on Post-Pubertal and Reproductive-Age Women. <i>Pharmaceuticals</i> 2025, <i>18</i>, 61". [PDF]

Pharmaceuticals (Basel)
Tassi A, Londero AP, Xholli A, Lanzolla G, Bertozzi S, Savelli L, Prefumo F, Cagnacci A.   +7 more
europepmc   +1 more source

Medroxyprogesterone Acetate Inhibits Tumorigenesis in Mouse Models of Oviductal High-Grade Serous Carcinoma. [PDF]

Cancers (Basel)
Zhai Y, Bedi K, Wu R, Feng Y, Green ME, Pearce CL, Pike MC, Fearon ER, Cho KR.   +8 more
europepmc   +1 more source

Physicians' Perceptions of Intravenous Estrogen for the Management of Acute Abnormal Uterine Bleeding. [PDF]

Cureus
Tjaden Peiffer A, Kistner M, Otto A, Schultz E, Wesolowski M, White P, Yang LC.   +6 more
europepmc   +1 more source